Kalytera Therapeutics, Inc.
Mailing Address: 41Thunderbird Drive
Novato, California
Head Office Address: 41 Thunderbird Drive
Novato, California
Contact Name: Robert Farrell Principal Regulator: British Columbia
Business e-mail address: bfarrell@kalytera.co Short Form Prospectus Issuer: Yes
Telephone Number: 415 218-3900 Reporting Jurisdictions: British Columbia, Alberta, Ontario
Fax Number: Stock Exchange: TSX Venture
Date of Formation: Oct 15 2004 Stock Symbol: KALY
Jurisdiction Where Formed: British Columbia Auditor: Kost Forer Gabbay & Kasierer
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 48349P Transfer Agent: TMX Trust Company
Financial Year-End: Dec 31 Size of Issuer (Assets): $5,000,001 to $25,000,000

View This Company's Documents